Trained Immunity Confers Broad-Spectrum Protection Against Bacterial Infections. by Ciarlo, E. et al.
M A J O R  A R T I C L E
Trained Immunity and Protection From Infections • jid 2020:222 (1 december) • 1869
The Journal of Infectious Diseases
 
Received 30 August 2019; editorial decision 20 December 2019; accepted 30 December 2019; 
published online December 31, 2019.
Correspondence: Thierry Roger, Infectious Diseases Service, Lausanne University Hospital 
and University of Lausanne, CLED.04.407, Chemin des Boveresses 155, CH-1066 Epalinges, 
Switzerland (Thierry.Roger@chuv.ch).
The Journal of Infectious Diseases®  2020;222:1869–81
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases 
Society of America. This is an Open Access article distributed under the terms of the Creative 
Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/
by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any 
medium, provided the original work is not altered or transformed in any way, and that the work 
is properly cited. For commercial re-use, please contact journals.permissions@oup.com
DOI: 10.1093/infdis/jiz692
Trained Immunity Confers Broad-Spectrum Protection 
Against Bacterial Infections
Eleonora Ciarlo,1 Tytti Heinonen,1 Charlotte Théroude,1 Fatemeh Asgari,2 Didier Le Roy,1 Mihai G. Netea,3,4 and Thierry Roger1
1Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Epalinges, Switzerland, 2Department of Biomedical Sciences, Humanitas 
University, Milan, Italy, 3Radboud Center for Infectious Diseases, and Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands, and 4Department for 
Genomics & Immunoregulation, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany
Background. The innate immune system recalls a challenge to adapt to a secondary challenge, a phenomenon called trained 
immunity. Training involves cellular metabolic, epigenetic and functional reprogramming, but how broadly trained immunity pro-
tects from infections is unknown. For the first time, we addressed whether trained immunity provides protection in a large panel of 
preclinical models of infections.
Methods. Mice were trained and subjected to systemic infections, peritonitis, enteritis, and pneumonia induced by Staphylococcus 
aureus, Listeria monocytogenes, Escherichia coli, Citrobacter rodentium, and Pseudomonas aeruginosa. Bacteria, cytokines, leuko-
cytes, and hematopoietic precursors were quantified in blood, bone marrow, and organs. The role of monocytes/macrophages, gran-
ulocytes, and interleukin 1 signaling was investigated using depletion or blocking approaches.
Results. Induction of trained immunity protected mice in all preclinical models, including when training and infection were ini-
tiated in distant organs. Trained immunity increased bone marrow hematopoietic progenitors, blood Ly6Chigh inflammatory mono-
cytes and granulocytes, and sustained blood antimicrobial responses. Monocytes/macrophages and interleukin 1 signaling were 
required to protect trained mice from listeriosis. Trained mice were efficiently protected from peritonitis and listeriosis for up to 5 
weeks.
Conclusions. Trained immunity confers broad-spectrum protection against lethal bacterial infections. These observations sup-
port the development of trained immunity-based strategies to improve host defenses.
Keywords.  innate immunity; infection; sepsis; trained immunity; peritonitis; Listeria; pneumonia; monocyte/macrophage; 
neutrophil; stem cell.
We used preclinical models to demonstrate that trained im-
munity confers broad-spectrum protection against bacterial 
infections. Trained immunity increased myeloid progenitors 
and circulating inflammatory monocytes and neutrophils, and 
depletion or neutralization of monocytes/macrophages and 
interleukin 1 signaling impaired trained immunity-mediated 
protection.
Innate immune cells express pattern recognition receptors spe-
cific for microbial-associated and danger-associated molecular 
patterns that are released by stressed or injured cells. The in-
teraction of pattern recognition receptors with microbial- or 
danger-associated molecular patterns activates intracellular 
signaling pathways that coordinate metabolic adaptation, epi-
genetic changes, and gene expression. The cellular and soluble 
mediators mobilized on infection regulate the development of 
the inflammatory response, the establishment of antimicrobial 
cellular and humoral responses, and the restoration of home-
ostasis once the pathogen has been contained or eradicated. 
Dysfunctions in these processes may have dramatic conse-
quences for the infected host, as observed in patients with sepsis 
[1–5].
It has long been thought that immunological memory was 
restricted to antigen-specific memory and a privilege of the 
adaptive immune system carried by lymphocytes. However, 
the description of systemic acquired resistance in plants, spe-
cific memory in invertebrates, antigen-specific memory by 
natural killer cells, and heterologous protection conferred by 
BCG, smallpox, and measles vaccines suggested the existence 
of a form of innate immune memory [6–13]. The term trained 
immunity was proposed to reflect the fact that the innate im-
mune system recalls or adapts to a first challenge to mount a 
robust response to a secondary challenge by a similar or dis-
similar microbial stimulus [14, 15]. The concept of innate im-
mune training was posed by showing that a nonlethal challenge 
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by Candida albicans improved the innate immune response of 
mice [16].
The molecular mechanisms underlying trained immunity 
include metabolic, epigenetic, and functional reprogramming 
of bone marrow myeloid precursors and innate immune cells. 
β-glucan, a fungal cell wall compound commonly used to study 
trained immunity, is detected by monocytes/macrophages 
through the dectin 1 receptor. Dectin 1 triggering activates a 
PI3K (phosphoinositol 3-kinase)/AKT/mTOR (mammalian 
target of rapamycin)/HIF-1α (hypoxia-inducible factor-1α) 
pathway that induces a metabolic shift toward aerobic glycol-
ysis, increases glutaminolysis that replenishes the tricarbox-
ylic acid cycle, activates the cholesterol synthesis pathway, and 
blocks the itaconate pathway [16–21]. As a consequence, metab-
olites such as fumarate, succinate, and mevalonate accumulate 
and act as cofactors of epigenetic modifiers and as amplifiers 
of trained immunity [19, 22]. β-glucan, C. albicans, and BCG 
vaccine induce genome-wide epigenetic changes, including 
monomethylation and trimethylation of histone (H) 3 lysine 
(K) 4 and acetylation of H3K27 at promoters and enhancers 
of genes associated with metabolic, immune, and host defense 
pathways [16, 23, 24]. Hence, trained monocytes/macrophages 
produce increased levels of cytokines (tumor necrosis factor 
[TNF], interleukin 1β [IL-1β], and interleukin 6 [IL-6]) when 
challenged with microbial compounds [16, 19, 24, 25].
Whether the induction of trained immunity confers a 
wide-ranging advantage during infections is unknown. 
Therefore, we questioned to which extent trained immunity 
protects from heterologous infections and at anatomic sites dis-
tant from the priming training site. Our results showed that a 
unique training scheme potently protected mice from clinically 
relevant pathogens inoculated through diverse routes to in-
duce peritonitis, systemic infections, enteritis and pneumonia. 
Trained immunity was particularly efficient at protecting mice 
from lethal listeriosis, which was dependent on monocytes/
macrophages and interleukin 1 (IL-1) signaling.
MATERIALS AND METHODS
Products used in this study are described in Supplementary 
Table 1.
Ethics Statement
Animal experimentation was approved by the Service des 
Affaires Vétérinaires, Direction Générale de l’Agriculture, de la 
Viticulture et des Affaires Vétérinaires, état de Vaud (Epalinges, 
Switzerland) under authorizations 876.9 and 877.9 and per-
formed according to Swiss and Animal Research: Reporting of 
In Vivo Experiments (ARRIVE) guidelines.
Mice, Cells, and Bacteria
C57BL/6J (wild-type, MyD88−/−, and Toll-like receptor [TLR] 
2−/−), and BALB/cByJ female mice (Charles River Laboratories) 
were 8–10 weeks old. Mice were housed under specific 
pathogen-free conditions (license VD-H04). Mice were free of 
mouse hepatitis and norovirus. Bone marrow cells were cul-
tured in Roswell Park Memorial Institute medium [26], supple-
mented with 50 IU/mL macrophage colony-stimulating factor 
(M-CSF) (ImmunoTools) to generate bone marrow–derived 
macrophages (BMDMs). BMDMs were trained as described 
elsewhere [18, 23]. Bone marrow cells were cultured for 24 
hours with 10  μg/mL zymosan and M-CSF, washed, cultured 
6 days in fresh medium containing M-CSF, detached, enumer-
ated, and seeded (2 × 106 cells/mL) in 96-well plates. 
Peritoneal cells obtained by a peritoneal lavage were plated 
at 105 cells/well in 96-well plate in 100  μL of Roswell Park 
Memorial Institute, washed after 4 hours, and stimulated for 
24 hours. Listeria monocytogenes 10403S, methicillin-resistant 
Staphylococcus aureus AW7, and Escherichia coli O18 were grown 
in brain-heart infusion broth, Citrobacter rodentium DBS100 in 
LB Broth Miller, Pseudomonas aeruginosa PAO1 in LB Broth 
Lennox, and C. albicans 5102 in yeast extract–peptone-dextrose 
[27–30]. Heat inactivation was performed for 2 hours at 70°C.
Flow Cytometry
Cells were collected and stained as described in the 
Supplementary Methods, using antibodies described in 
Supplementary Table 1 [31, 32]. Data were acquired using an 
Attune NxT Flow Cytometer (Thermo Fisher Scientific) and 
analyzed using FlowJo_V10_CL software (FlowJo). Gating 
strategies are presented in Supplementary Figure 1.
Whole-Blood Bactericidal Assay and Cytokine Production
The whole-blood assay is described in the Supplementary 
Methods. Cytokines were quantified by means of enzyme-
linked immunosorbent assay, a ProCarta kit (Invitrogen), and 
a Bio-Plex 200 system (Bio-Rad) [33].
Isolation of Bone Marrow Monocytes and Chromatin Immunoprecipitation
The isolation of bone marrow monocytes and chromatin 
immunoprecipitation were performed as described in the 
Supplementary Methods [34].
In Vivo Models
Age-matched female mice were randomly divided into groups. 
Mice were injected intraperitoneally with 1 mg of zymosan or 
heat-killed C. albicans or intravenously with 0.1 mg of zymosan 
before bacterial challenge. Staphylococcal sepsis was also tested 
in BALB/cByJ mice. Enteritis was induced in TLR2−/− mice de-
prived of food for 8 hours before bacterial challenge. The role 
of monocytes/macrophages was assessed using mice injected 
intraperitoneally with 200  µL of clodronate or phosphate-
buffered saline liposomes (LIPOSOMA research) 7 and 4 days 
before infection. The role of polymorphonuclear neutrophils 
(PMNs) was assessed using mice injected intraperitoneally with 
100 µg of 1A8 anti-Ly6G monoclonal antibody (mAb) or 2A3 
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immunoglobulin G2a isotype control mAb (Bio X Cell) 6 days, 
3 days, and 1 day before infection. 
Cell depletion (≥95% and ≥60% for monocytes/macrophages 
and PMNs, respectively) was evaluated on the day of infection 
by means of flow cytometry. Depletion in trained mice reduced 
PMNs to levels similar to those measured in isotype con-
trol mAb-treated untrained mice (mean [standard deviation], 
3.7 [1.2] vs 2.7 [0.7] × 106 PMNs/mL; n = 8; P > .05). To assess 
the role of IL-1 signaling, mice were injected intraperitoneally 
with 500 µg of anakinra (Kineret; Sobi) 6, 5, 4, and 3 days be-
fore infection. Body weight, severity score, and survival were 
recorded at least once daily [35].
Statistical Analyses
Graphics represent data obtained from individual mice, or 
boxes with minimum-to-maximum whiskers. Data were ana-
lyzed for normal distribution and homogeneity of variances and 
compared with the appropriate parametric (2-tailed unpaired 
Student t ) or nonparametric (2-tailed Mann-Whitney) statis-
tical test. The false discovery rate was controlled, when neces-
sary. The Kaplan-Meier method was used for building survival 
curves, and differences were analyzed using the log-rank sum 
test. Analyses were performed using PRISM version 8.0.1 soft-
ware (GraphPad Software). P values were 2 sided. 
RESULTS
Impact of Trained Immunity on E. coli Peritonitis
C57BL/6J mice were trained with zymosan, a cell wall preparation 
rich in β-glucan, given intraperitoneally 7 and 3 days before infec-
tion [18] unless specified otherwise (Figure 1A). In a first model, 
control and trained mice were challenged intraperitoneally with 
E.  coli. Trained mice coped much better with peritonitis than 
control mice, showing lower severity scores, absence of E.  coli 
dissemination in the blood, and improved survival rates (92% 
vs 23% survival; P < .001) (Figure 1B). Cytokine levels were in-
creased in the blood of trained mice (Figure 1B), likely reflecting 
diffusion from the peritoneal cavity in which trained cells re-
sponded massively to E. coli. 
Supporting this assumption, peritoneal cells from trained mice 
produced high levels of TNF and IL-6 in response to lipopol-
ysaccharide (LPS) stimulation (Figure  1C). Moreover, the 
peritoneal cavity of trained mice contained more leukocytes, 
among which were more phagocytes (Figure 1D). PMNs were 
increased 8.2-fold, and there was a shift in the macrophage pop-
ulation. In control mice, the peritoneal cavity contained mainly 
homeostatic large peritoneal macrophages (LPMs) that virtu-
ally disappeared in trained mice at the expense of inflammatory 
and bactericidal small peritoneal macrophages (SPMs).
Impact of Trained Immunity on Systemic Staphylococcal and Listeria 
Infections
To explore whether trained immunity protected from systemic 
infections, C57BL/6J mice were injected intravenously with 
methicillin-resistant S.  aureus. Trained mice survived better 
than control mice (31% vs 0% survival; P  =  .006) and had 
10-fold less bacteria in blood 2 days after infection (Figure 2A). 
Very similar results were obtained using BALB/cByJ mice 
(Supplementary Figure 2A), and subsequent experiments were 
all performed using C57BL/6J mice.
Mice were challenged intravenously with a lethal dose of 
L. monocytogenes. Most strikingly, all trained mice survived in-
fection, whereas all control mice died within 5 days (Figure 2B). 
Bacteria were not detected in blood collected from trained mice 
2 and 3 days after infection, whereas up to 105 colony-forming 
units/mL were measured in the circulation of control mice 
(Figure  2B and Supplementary Figure 2B). Trained mice had 
2–3-log lower counts of L. monocytogenes in spleen, liver, and 
kidney (Figure 2B), and L. monocytogenes was undetectable in 
organs collected from mice surviving infection for 1–2 months. 
Confirming an efficient control of bacterial burden in 
trained mice, cytokines and chemokines were detected at much 
lower concentrations in blood collected 3 days after infection 
(Figure 2B). Training mice with zymosan given intravenously as 
a single dose 7 days before infection also efficiently reduced bac-
terial burden, suggesting that training can be induced through 
diverse routes (Figure 2C). Because training was demonstrated 
by challenging mice with heat-killed C. albicans [16], we ques-
tioned whether a similar approach would protect from listeri-
osis. Mice trained with heat-killed C. albicans were powerfully 
protected from lethal listeriosis (P = .002) and had greatly re-
duced bacteremia (Figure  2D). Thus, trained immunity effi-
ciently protected mice from systemic bacterial infections.
Impact of Trained Immunity on Enteritis and Pneumonia
To extend the panel of microorganisms and routes of inocula-
tion tested, we developed models of enteritis and pneumonia. 
Enteritis induced by C.  rodentium was established in TLR2−/− 
mice, because the bacteria are cleared quickly in immunocom-
petent animals. All mice lost weight and had some diarrhea, 
but none died. Trained and control mice recovered their ini-
tial weights 7 and 18 days after infection, respectively. Trained 
mice showed improved weight from day 7 to day 30 (P < .01) 
(Figure 3A). Pneumonia was induced by an intranasal challenge 
with P. aeruginosa. The survival of trained mice was largely im-
proved (P =  .02) (Figure 3B). Overall, trained immunity pro-
tected mice in all the preclinical models tested, suggesting the 
enhancement of broad mechanisms of defense.
Impact of Trained Immunity on Blood Antimicrobial Activity and 
Myelopoiesis
Trained immunity protected mice remarkably well from sys-
temic listeriosis (92 of 96 trained mice survived vs 0 of 74 con-
trol mice; n = 5 experiments). We reasoned that blood should 
provide an efficient barrier against L.  monocytogenes burden. 
Ex vivo, the blood of trained mice limited the growth of 
L. monocytogenes better than that of control mice (Figure 4A), 
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and it was more reactive to microbial products, as shown by in-
creased production of TNF and IL-6 in response to LPS, CpG, 
Pam3CSK4, L. monocytogenes and C. albicans (Figure 4B). 
We then quantified leukocytes in control and trained mice, 
using blood collected before and 2  days after infection with 
L.  monocytogenes (Figure  4C). Training increased leukocyte 
counts 1.6 fold, reflecting more Ly6Chigh, Ly6Cint, and Ly6Clow 
monocytes (inflammatory, intermediate, and nonclassic mono-
cytes) and PMNs (7.6-, 3.9-, 1.9-, and 4.7-fold increase, respec-
tively, vs control; P < .05). In trained mice, Ly6Chigh and Ly6Cint 
monocytes expressed more CD11b/Itgam (2.5- and 1.8-fold 
higher mean fluorescence intensity), indicative of a primed/
activated phenotype (Supplementary Figure 3). Conversely, 
PMNs expressed lower CD11b (2.5 lower mean fluorescence 
intensity), which is associated with an immature status [36]. The 
absolute numbers of T and B lymphocytes were not affected.
L.  monocytogenes induced a massive depletion of leukocytes 
2 days after infection, which was less pronounced in trained mice 
(2.9- vs 11.5-fold decrease in trained vs control mice) (Figure 4C). 
Ly6Chigh and Ly6Clow monocytes were more preserved in trained 
mice. PMNs were rather stable in trained mice, but they decreased 
9.9-fold in control mice. T cells and B cells decreased 4–7-fold in 
trained mice, but 40-fold in control mice. The relative preserva-
tion of blood leukocytes suggested an enhanced hematopoiesis in 
trained mice. Indeed, the bone marrow of trained mice contained 
more long-term hematopoietic stem cells and more multipotent 
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Figure 1. Trained immunity protects from Escherichia coli peritonitis. A, Experimental model to study protection from infection mediated by trained immunity. Unless 
specified otherwise, training was induced by 2 intraperitoneal injections of 1 mg zymosan, performed 4 days apart (at −7 and −3 days) using C57BL/6J mice. B, Control and 
trained mice were challenged intraperitoneally with 104 colony-forming units (CFUs) of E. coli. Severity score and survival were recorded. Blood was collected 18 hours after 
infection to quantify bacteria (Dashed line indicates lower limit of detectio) and cytokines using Luminex technology (n = 6 mice per group). C, Tumor necrosis factor (TNF) 
and interleukin 6 (IL-6) production by peritoneal cells from control and trained mice exposed ex vivo for 6 hours (TNF) or 24 hours (IL-6) to 10 ng/mL lipopolysaccharide. D, 
Leukocytes in the peritoneal cavity of control and trained mice before infection (n = 4–5 mice). *P ≤ .05; †P ≤ .001. Abbreviations: CCL, C-C motif chemokine ligand; CXCL, 
C-X-C motif chemokine ligand; IFN, interferon; IL-1β (etc), interleukin 1β (etc); LPMs, large peritoneal macrophages; PMNs, polymorphonuclear neutrophils; SPMs, small 
peritoneal macrophages; TNF, tumor necrosis factor.
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A MRSA, 107 CFUs intravenously
L. monocytogenes, 9 × 104 CFUs intravenously
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P = .002
Control (n = 8)
Trained with
C. albicans (n = 8)
Figure 2. Trained immunity protects from systemic staphylococcal and Listeria infections. A, Control and trained mice were challenged intravenously with 107 colony-
forming units (CFUs) of methicillin-resistant Staphylococcus aureus (MRSA). Survival was recorded. Blood was collected 2 days after infection to quantify bacteria. B, Control 
and trained mice were challenged intravenously with 9 × 104 CFUs of Listeria monocytogenes. Survival was recorded. Blood, spleen, liver, and kidney were collected 3 days 
after infection to quantify bacteria. Dashed line indicates lower limit of detection. Blood was collected 2 days after infection to quantify cytokines using Luminex tech-
nology (n = 6 mice per group). Dashed line indicates upper limit of detection. C, Control mice and mice trained with zymosan intravenously (0.1 mg at day −7) were infected 
intravenously with 105 CFUs of L. monocytogenes. Blood was collected 2 days after infection to quantify bacteria. D, Control mice and mice trained with heat-killed Candida 
albicans were infected intravenously with 1.9 × 105 CFUs of L. monocytogenes. Survival was recorded, and blood was collected 2 days after infection to quantify bacteria. 
*P ≤ .05; †P ≤ .01; ‡P ≤ .001. Abbreviations: CCL, C-C motif chemokine ligand; CXCL, C-X-C motif chemokine ligand; IL-1β (etc), interleukin 1β (etc); TNF, tumor necrosis factor.
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Role of Monocytes/Macrophages and IL-1 Signaling
We analyzed the impact of depleting monocytes/macrophages 
by treating mice with clodronate liposomes during induction 
of training. Clodronate treatment fully abolished the protection 
conferred by training (Figure 5A). Because PMNs were also in-
creased during training, we tested the impact of PMN depletion 
using anti-Ly6G mAb. In both trained and control mice, the 
depletion of PMNs modified neither survival nor bacteremia 
(Figure 5B). Two days after infection, PMNs were still fully de-
pleted from the blood of anti-Ly6G mAb-treated mice, whether 
trained mice or control mice (Figure 5C). These observations 
suggested that monocytes are central effector cells for the pro-
tection against listeriosis conferred by trained immunity.
We tested the contribution of IL-1β/IL-1 signaling, because 
IL-1β has been proposed to play a role in trained immunity [37]. 
IL-1β was detected at higher concentrations in blood from trained 
mice (Figure 6A). Blood from trained mice showed a trend toward 
producing higher levels of IL-1β on exposure to L. monocytogenes, 
and BMDMs trained in vitro with zymosan produced higher levels 
of IL-1β in response to L. monocytogenes (Figure 6A). 
Because MyD88 is the adaptor signaling molecule down-
stream interleukin 1R, we quantified leukocytes as a surrogate 
of IL-1 signaling-mediated training in MyD88−/− mice. None 
of the changes observed in trained wild-type mice were de-
tected in trained MyD88−/− mice, which behaved similarly to 
untrained MyD88−/− mice (Supplementary Figure 4). The role 
of IL-1 signaling was tested in mice treated daily for 4 days with 
recombinant IL-1 receptor antagonist (anakinra) during the 
induction of trained immunity (Figure 6B-C). Severity score 
and weight loss (P  <  .01 and P  <  .001, respectively) were in-
creased in anakinra-treated mice. Accordingly, 3 of 8 anakinra-
treated trained mice died of listeriosis, whereas all trained mice 
survived infection (P  =  .06). The partial effect on mortality 
rate was related to a partial (1.4-fold) reduction in Ly6Chigh 
monocytes (P  =  .02) (Figure 6C). These data supported the 
assumption that IL-1 signaling is involved in the antilisterial 
activity conferred by trained immunity. Interestingly, chro-
matin immunoprecipitation assays performed on monocytes 
isolated 3 weeks after the induction of training revealed in-
creased marks associated with active chromatin (H3K4me1 and 
H3K4me3, Figure 6D) and trained immunity [16, 23, 24].
Length of Protection Conferred by Trained Immunity
The length of protection conferred by trained immunity against 
lethal bacterial infections is unknown. To start filling that gap, 
we analyzed mice trained up to 5 weeks earlier (Figure  7A). 
In the peritoneal cavity, leukocytes steadily increased from 2 
to 5 weeks after training, reaching a maximum after 5 weeks 
(Figure 7B). The decreased number of LPMs remained drastic 
at all time points, whereas the number of SPMs increased 
2–5 weeks after training. PMNs reached a maximum value 2 
week after training and remained stable for up to 5 weeks. In 
line with these observations, mice trained 5 weeks earlier were 
protected from E. coli peritonitis, as shown by reduced weight 
loss and bacterial dissemination into the blood compared with 
untrained mice (Figure  7C). Blood cytokine levels increased 
mainly 1–2 weeks after training, and returned to baseline levels 
5 weeks after challenge (Figure 7D). Moreover, blood leukocyte 
counts were back to normal 5 weeks after training (Figure 7D). 
Impressively, mice trained 1, 2, 4, or 5 weeks earlier were all pro-
tected from listeriosis, in term of both survival and bacteremia 
(Figure 7D).
DISCUSSION
We report the first broad analysis of the impact of trained im-
munity on bacterial infections. Trained immunity protected 
mice from a large panel of clinically relevant bacterial patho-
gens inoculated systemically and locally to induce peritonitis, 
enteritis, and pneumonia.
In all models, bacterial dissemination was controlled. In the 
peritonitis model, this results from a massive accumulation 
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Figure 3. Trained immunity protects from enteritis and pneumonia. A, Weight of control and trained mice challenged intragastrically with 9 × 108 colony-forming units 
(CFUs) of Citrobacter rodentium. B, Survival of control and trained mice challenged intranasally with 1.6 × 107 CFUs of Pseudomonas aeruginosa. 
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represent <10% of peritoneal macrophages, which are composed 
mainly of self-maintaining LPMs. Local inflammation triggers 
the migration of LPMs to the omentum, where these cells pro-
duce growth factors and chemokines that stimulate myelopoiesis 
and induce the influx of PMNs and inflammatory monocytes, 
which are precursors of SPMs [38]. Hence, LPMs and SPMs play 
key roles as initiator and effector cells of trained immunity when 
training and infection occur in the peritoneum.
Stimulation of myelopoiesis greatly increased blood leu-
kocyte counts, above all those of PMNs and Ly6Chigh inflam-
matory monocytes exhibiting a primed/activated phenotype. 
Changes in peripheral blood gave an indubitable advantage to 
trained mice during systemic infections, as demonstrated in 
models of listeriosis and staphylococcal infection. The picture 
was rather unexpected in the model of listeriosis, because al-














































































































































































































































































































































Figure 4. Trained immunity increases blood antimicrobial activity and stimulates myelopoiesis. A, Bacteria in whole blood from control and trained mice exposed ex vivo 
for 2 hours to 1.2 × 103 colony-forming units (CFUs)/mL of Listeria monocytogenes. B, Tumor necrosis factor (TNF) and interleukin 6 (IL-6) production by whole blood from 
control and trained mice exposed ex vivo for 6 hours (TNF) or 24 hours (IL-6) to 10 ng/mL lipopolysaccharide (LPS), 10 μmol/L CpG, 100 ng/mL Pam3CSK4, 10
7 heat-killed 
L. monocytogenes, and 10 mg/mL heat-killed Candida albicans. C, Leukocytes in blood collected from control and trained mice before infection (left part) and 2 days after 
an intravenous challenge with 1.1 × 105 CFUs of L. monocytogenes (right part) (n = 5 mice per group). D, Long-term and short-term hematopoietic stem cells (LT-HSCs and 
ST-HSCs), multipotent progenitors (MPPs), MPP2, MPP3, and MPP4 in the bone marrow of control and trained mice. *P ≤ .05; †P ≤ .01. Abbreviation: PMNs, polymorphonu-
clear neutrophils.
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times the LD100. Results of cell depletion experiments suggested 
that monocytes/macrophages were the main drivers of pro-
tection. This is in agreement with the fact that inflammatory 
monocytes were essential whereas PMNs were dispensable for 
clearing bacteria during the early and late phases of systemic 
infection by L. monocytogenes [39]. Circulating inflammatory 
monocytes migrated to foci of infection in liver and spleen to 
give rise to TNF- and inducible nitric oxide synthase–produ-
cing dendritic cells and monocyte-derived macrophages that 
replenished Kupffer cells dying through necroptosis. This 
helped enhance antibacterial immunity and restore tissue in-
tegrity [40, 41].
Trained immunity protected mice from enteritis and pneu-
monia, pointing to distant effects. Intraperitoneal injections 
of LPS induced epigenetic reprogramming of brain resident 
macrophages and modulated neuropathology in models of 
Alzheimer disease and stroke [42]. The broad effects of trained 
immunity during infections may result from the action of sol-
uble mediators that directly or indirectly stimulate the response 
of intestinal, airway, and lung parenchyma cells or resident 
immune cells. For example, adenoviral infection improved 
the activity of self-renewing memory alveolar macrophages 
that promoted neutrophilia and protected from Streptococcus 
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Figure 5. Monocytes/macrophages are essential to protect trained mice from listeriosis. A, Experimental model to study the role of monocytes/macrophages in trained 
immunity (left) and survival of mice treated with clodronate or phosphate-buffered saline (PBS) liposomes and challenged intravenously with 1.4 × 105 colony-forming units 
(CFUs) of Listeria monocytogenes (right). B, Experimental model to study the role of polymorphonuclear neutrophils (PMNs) in trained immunity (left). Survival of mice treated 
with anti-Ly6G or isotype control antibody and challenged intravenously with 1.3 × 105 CFUs of L. monocytogenes (middle) and bacteria in blood collected 18 hours after in-
fection (right). C, Leukocytes in blood collected 2 days after infection with L. monocytogenes (n = 8 mice per group.) *P ≤ .01; †P ≤ .01; ‡P ≤ .001.
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Bone marrow hematopoietic stem and progenitor cells 
adapted to acute and chronic peripheral inflammation and 
infection through cell-extrinsic and cell-intrinsic mechan-
isms, increasing proliferation and skewing toward the myeloid 
lineage to provide activated innate immune cells [44–46]. Our 
training protocol increased the number of hematopoietic stem 
cells and MPPs, accounting for higher leukocyte counts before 
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Figure 6. Interleukin 1 (IL-1) signaling participates to protect trained mice from listeriosis. A, Interleukin 1β (IL-1β) concentrations in blood collected from control and 
trained mice at day 0 (left), in whole blood from control and trained mice exposed ex vivo for 6 hours to 108 heat-killed Listeria monocytogenes (middle), and in cell culture 
supernatants of control and trained bone marrow–derived macrophages cultured for 24 hours with or without 1 live L. monocytogenes per cell (right). B, Experimental model to 
study the role of IL-1 signaling in trained immunity (top). Severity score, weight loss, and survival (bottom) of mice trained with or without anakinra treatment and challenged 
intravenously with 1.3 × 105 colony-forming units (CFUs) of L. monocytogenes (n = 8 mice per group). C, Leukocytes in blood collected just before infection from mice trained 
with or without anakinra (n = 9–10 mice per group). D, H3K4me1, H3K4me3 and H3K27ac signal at the Il1b promoter of bone marrow monocytes isolated from mice trained 
or not 3 weeks earlier were quantified by chromatin immunoprecipitation followed by real-time polymerase chain reaction and expressed as percentage of input (n = 4 mice 
per group). *P ≤ .05; †P ≤ .01; ‡P ≤ .001. Abbreviation: PMNs, polymorphonuclear neutrophils.
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in naive mice of long-term hematopoietic stem cells or bone 
marrow cells collected from mice trained with β-glucan and 
BCG vaccine increased the proportion of blood Gr1+CD11b+ 
myeloid cells and protected from pulmonary tuberculosis [25, 
44]. We are performing experiments to delineate the length of 
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Figure 7. Trained immunity protects from peritonitis and listeriosis for at least 5 weeks. A, Experimental model to study the effects of training over time. B, Leukocytes in 
the peritoneal cavity of mice trained 0, 2, 4, and 5 weeks earlier (n = 5 mice per group). C, Weight loss and bacteria in blood collected 2 days after an intraperitoneal challenge 
with 5 × 104 colony-forming units (CFUs) of Escherichia coli. D, Leukocytes (n = 8–10) and cytokines (n = 6) in blood of mice trained 0, 1, 2, 4 and 5 weeks earlier (top). Survival 
and bacteria in blood collected 2 days after infection of mice challenged intravenously with 1.1 × 105 CFUs of Listeria monocytogenes). *P ≤ .05. Abbreviations: IFN, interferon; 
IL-6 (etc), interleukin 6 (etc); LPMs, large peritoneal macrophages; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; NS, not significant; PMNs, 
polymorphonuclear neutrophils; SPMs, small peritoneal macrophages; TNF, tumor necrosis factor. 
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will be valuable for preclinical and clinical development of 
trained immunity-based therapeutics.
The diversity of the models of infection tested supports wide 
effects of trained immunity. Work will be required to establish 
whether trained immunity protects from additional bacterial, 
fungal and viral infections. Trained immunity is most typically 
induced with β-glucan, which promotes T-helper (Th) 1/Th17 
proinflammatory responses essential to fight bacteria, viruses, 
and fungi. However, training might be tipped toward Th2 im-
mune responses beneficial during parasitic infections [47].
IL-1β has gained attention as a possible hub regulating trained 
immunity [24, 37, 44–46]. Uninfected trained mice expressed in-
creased blood levels of IL-1β, and treatment with anakinra com-
promised trained immunity, indicating that IL-1 signaling played 
a role. Trained peripheral blood mononuclear cells produced 
higher levels of IL-1β, and IL-1β itself fueled human monocytes 
to produce higher levels of cytokines on stimulation [17]. In vivo, 
BCG vaccine–induced IL-1β production was correlated with the 
capacity to control viremia in healthy subjects challenged with 
yellow fever vaccine [24]. IL-1 family members can affect trained 
immunity through manifold mechanisms [37]. Interestingly, 
training mice with β-glucan sustained IL-1β signaling that pro-
moted glycolytic activity and proliferation of hematopoietic stem 
and progenitor cells [44]. This aspect is highly relevant for lis-
teriosis, which affects blood leukocytes and constrains vigorous 
myelopoiesis. Inflammasomes control IL-1β secretion and are 
likely to be involved in trained immunity. Supporting this hy-
pothesis, feeding Ldr−/− atherosclerotic mice a Western diet in-
duced an oxidized low-density lipoprotein/NOD-like receptor 
family, pyrin domain containing 3 (NLRP3)/IL-1 axis, leading to 
the establishment of trained immunity [45].
Induction of trained immunity is an attractive approach to 
increase vaccine efficacy and resistance to pathogens. Training 
with β-glucan counteracted endotoxin-mediated immune tol-
erance associated with poor outcome in sepsis [3, 4, 21, 48]. 
However, immunotherapies may have doubled-edge sword ef-
fects. Low-grade inflammation sustained by trained immu-
nity may be involved in the pathophysiology of chronic and 
autoinflammatory disorders [49]. Monocytes from patients with 
hyperimmunoglobulin D syndrome have a trained phenotype 
[22] and Western diet feeding induced trained immunity [45]. 
Interfering with the sensing of training inducers, IL-1 signaling, 
and inflammation, metabolic and epigenetic changes may be ex-
ploited to avoid pathogenic processes linked to trained immunity. 
For instance, trained immunity induced by helminth products 
provided an anti-inflammatory environment, attenuating the de-
velopment of experimental autoimmune encephalomyelitis [50].
In summary, induction of trained immunity remodeled bone 
marrow and blood cellular compartments, providing efficient 
barriers against bacterial infections. Protection was remark-
ably broad when considering the pathogens and sites of in-
fection tested. These data support the development of trained 
immunity-based strategies to improve the efficacy of vaccines 
and host defenses against infections, and they may give clues 
about the pathological processes underlying inflammatory and 
autoimmune disorders.
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